21 August 2024
\n \n \n \nU-Ploid Biotechnologies joins the BioEscalator to develop groundbreaking therapeutics that improve egg quality and revolutionise IVF.
\n \n\n \n \n18 July 2024
\n \n \n \nWe are delighted to welcome RE-AIM Therapeutics to the BioEscalator community, a start-up focused on developing antibody-based curative therapies for inflammatory disorders, such as psoriasis and inflammatory bowel disease.
\n \n\n \n \n18 July 2024
\n \n \n \nSiGenex is advancing genomic medicine with its innovative, artificial intelligence-powered in-hospital sequencing platform. The company's technology is designed to transform how hospitals, clinics, and medical centres perform targeted next-generation sequencing (NGS) tests.
\n \n\n \n \n17 July 2024
\n \n \n \nBioarchitech's departure from the BioEscalator marks the beginning of an exciting new phase for the pioneering cancer therapy company, as it transitions to the next stage of its innovative journey.
\n \n\n \n \n17 July 2024
\n \n \n \nThe 5th Annual BioEscalator Pitch Battle was an exciting showcase of fierce competition and groundbreaking innovations. With seven categories, ten companies competing for the top spot, and \u00a32000 in prize money at stake, the judges faced a formidable task in selecting the winners.
\n \n\n \n \n23 June 2024
\n \n \n \nOur Business Manager, Dr Claire Shingler, participated in a collaborative project highlighting the strong partnerships between academic and industry professionals in the Medical Sciences Division. In this project, Claire shared her story and discussed her role in managing Oxford's biomedical science incubator. She discussed her motivations and the rewarding experiences she has had in supporting innovative spin-outs.
\n \n\n \n \n5 June 2024
\n \n \n \nMediMab Biotherapeutics announces its graduation from the BioEscalator. This move represents a major milestone for the company as it relocates to Abingdon Science Park, positioning itself for further expansion and cutting-edge research in immuno-oncology.
\n \n\n \n \n30 April 2024
\n \n \n \nBrad Loncar visited the BioEscalator to learn more about how we support the growth of innovative medical science companies.
\n \n\n \n \n6 November 2023
\n \n \n \nThroughout her apprenticeship, Fabiha has shown remarkable determination in learning and mastering the skills required for her role.
\n \n\n \n \n15 October 2023
\n \n \n \nThe BioEscalator recently marked its 5th anniversary with a celebration that showcased the impressive journeys of some of its current and graduated biotech companies.
\n \n\n \n \n30 August 2023
\n \n \n \nThe BioEscalator community engaged with the talented cohort of innovators from The Africa Oxford Health Innovation Platform (AfOx-HIP) programme, a collaborative initiative by the University of Oxford fostering innovation and entrepreneurship to address crucial health challenges in Africa.
\n \n\n \n \n31 July 2023
\n \n \n \nDr. Khwaja Islam's Apprentice Manager Award nomination shows his commitment to providing excellent apprenticeship training and cultivating a skilled workforce for the future.
\n \n\n \n \n19 July 2023
\n \n \n \nThe event provided an excellent opportunity for BioEscalator residents to connect and build relationships with their colleagues and neighbours outside of the workplace. It also offered a much-needed break from the daily work routine.
\n \n\n \n \n12 July 2023
\n \n \n \nPitching a business idea to potential investors is nerve-wracking for any entrepreneur. The pressure to effectively convey a company's vision, potential, and market viability can be overwhelming. However, for the innovative companies associated with the BioEscalator, this task became an opportunity to shine at the fourth annual BioEscalator Pitch Battle.
\n \n\n \n \n19 June 2023
\n \n \n \nThe BioEscalator, alongside resident company Alethiomics, was presented with the award, showing commitment towards sustainable practices.
\n \n\n \n \n18 May 2023
\n \n \n \nThe BioEscalator and Oxford University Innovation teamed up to hold an event to showcase the state-of-the-art laboratory facilities at the University of Oxford to resident BioEscalator companies and start-ups from the Oxfordshire innovation ecosystem.
\n \n\n \n \n9 October 2022
\n \n \n \nStarting up your own business is challenging at the best of times; business plans, funding, licensing and IP are just a few of the hurdles founders face. In addition to the global pandemic and the current financial crisis in the UK, SMEs are under more pressure than ever.
\n \n\n \n \n26 September 2022
\n \n \n \nNucleome Therapeutics has outgrown its space at the BioEscalator and moved to pastures new. The company will continue its growth journey at The Oxford Science Park.
\n \n\n \n \n31 July 2022
\n \n \n \nPepGen is the last of the original cohort of companies that moved into the BioEscalator when it first opened. The new PepGen headquarters in Boston, USA, will manage late-stage preclinical testing and clinical and regulatory functions.
\n \n\n \n \n11 July 2022
\n \n \n \nInfinitopes win the battle with an excellent presentation from CEO Jonathan Kwok on how the company is pushing the boundaries of science and medicine to identify hidden tumour targets to create high-efficiency vaccines.
\n \n\n \n \n